comparemela.com
  1. Home
  2. Live Updates
  3. Urol Int - Breaking News

Latest Breaking News On - Urol int - Page 1 : comparemela.com

Vaccitech Doses First Patient in PCA001, a Prostate Cancer Phase 1/2 Clinical Trial of VTP-850 Immunotherapeutic Candidate in Men with Rising PSA after Definitive Local Therapy

OXFORD, United Kingdom, June 12, 2023 Vaccitech plc , a clinical-stage biopharmaceutical company engaged in the discovery and development of novel immunotherapeutics for the treatment of. | June 12, 2023

United kingdomUnited statesMeg marshallJ clin oncUniversity of oxfordExchange commissionBill enrightChief executive officerChief medical officerPrivate securities litigation reform actAnnual reportQuarterly reportsUrol intProstate cancerCancer united kingdomAbout prostate cancer

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.